Ultrasound in percutaneous absorption

Enhancement in Drug Delivery

Volumn , Issue , 2006, Pages 317-330

  Kost, Joseph ^a   Wolloch, Lior ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950885597     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (77)

1. Lavon, I., and J. Kost. 2004. Ultrasound and transdermal drug delivery. Drug Discov Today 9:670.
2. Mitragotri, S., and J. Kost. 2004. Low-frequency sonophoresis: A review. Adv Drug Deliv Rev 56, 589.
3. Prausnitz, M.R., S. Mitragotri, and R. Langer. 2004. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115.
4. Wells, P.N.T. 1993. Physics of ultrasound. In Ultrasonic exposimetry, ed. P.A. Lewin, 35. Boca Raton, FL: CRC Press.
5. Suslick, K.S. 1988. Ultrasound: its chemical, physical and biological effects, New York: VCH.
6. Mitragotri, S. 2005. Healing sound: The use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 4:255.
7. van Wamel, A., et al. 2004. Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics 42:903.
8. Leveillee, R.J., and L. Lobik, 2003. Intracorporeal lithotripsy: Which modality is best? Curr Opin Urol 13:249.
9. Hong, J.P., et al. 2004. Ultrasound-assisted lipoplasty treatment for axillary bromidrosis: Clinical experience of 375 cases. Plast Reconstr Surg 113:1264.
10. Takahashi, S., et al. 2003. Exposure of the coronary artery using an ultrasonic scalpel. J Thorac Cardiovasc Surg 125:1533.
11. Whaley, D.H., D.L. Adamczyk, and E.A. Jensen. 2003. Sonographically guided needle localization after stereotactic breast biopsy. Am J Roentgenol 180:352.
12. Lubbers, J., R.T. Hekkenberg, and R.A. Bezemer. 2003. Time to threshold (TT), a safety parameter for heating by diagnostic ultrasound. Ultrasound Med Biol 29:755.
13. Williams, A.R. 1986. Ultrasound: biological effects and potential hazards, New York: Academic Press.
14. Clarke, L., A. Edwards, and E. Graham. 2004. Acoustic streaming: An in vitro study. Ultrasound Med Biol 30:559.
15. Nightingale, K.R., P.J. Kornguth, and G.E. Trahey. 1999. The use of acoustic streaming in breast lesion diagnosis: A clinical study. Ultrasound Med Biol 25:75.
16. Shi, X., et al. 2001. Color doppler detection of acoustic streaming in a hematoma model. Ultrasound Med Biol 27:1255.
17. Levy, D., et al. 1989. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J Clin Invest 83:2074.
18. Tachibana, K. 1992. Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasound exposure. Pharm Res 9:952.
19. Mitragotri, S., D. Blankschtein, and R. Langer. 1995. Ultrasound-mediated transdermal protein delivery. Science 269:850.
20. Mitragotri, S., D. Blanckschtein, and R. Langer. 1996. Transdermal drug delivery using lowfrequency sonophoresis. Pharm Res 13:411.
21. Yamashita, N., et al. 1997. Scanning electron microscopic evaluation of the skin surface after ultrasound exposure. Anat Rec 247:455.
22. Boucaud, A., et al. 2001. Clinical, histologic, and electron microscopy study of skin exposed to lowfrequency ultrasound. Anat Rec 264:114.
23. Fellinger, K., and J. Schmidt. 1954. Klinik and therapies des chromischen gelenkreumatismus, 549. Austria: Maudrich Vienna.
24. http://www.sontra.com.
25. Kost, et al. 1988. Ultrasound enhancement of transdermal drug delivery. Cambridge, MA: Massachusetts Institute of Technology. US Patent 4,767,402.
26. Boucaud, A., et al. 2001. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin. Int J Pharm 228:69.
27. Kost, J. 1989. Ultrasound as a Transdermal Enhancer. In Percutaneous absorption, ed. Maibach, H. I, 595. New York and Basel: Marcel Dekker.
28. Mitragotri, S., and J. Kost. 2001. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm Res 18:1151.
29. Bommannan, D., et al. 1992. Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res 9:559.
30. Fang, J.Y., et al. 1999. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate. Int J Pharm 191:33.
31. Mutoh, M., et al. 2003. Characterization of transdermal solute transport induced by low-frequency ultrasound in the hairless rat skin. J Control Release 92:137.
32. Mitragotri, S., et al. 1995. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci 84:697.
33. Johnson, M.E., et al. 1996. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J Pharm Sci 85:670.
34. Cagnie, B. 2003. Phonophoresis versus topical application of ketoprofen: Comparison between tissue and plasma levels. Phys Ther 83:707.
35. Tachibana, K., and S. Tachibana. 1991. Transdermal delivery of insulin by ultrasonic vibration. J Pharm Pharmacol 43:270.
36. Merino, G., et al. 2003. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J Control Release 88:85.
37. Boucaud, A., et al. 2002. Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J Control Release 81:113.
38. Smith, N.B., S. Lee, and K.K. Shung. 2003. Ultrasound-mediated transdermal in vivo transport of insulin with low-profile cymbal arrays. Ultrasound Med Biol 29:1205.
39. Lee, S., R.E. Newnham, and N.B. Smith. 2004. Short ultrasound exposure times for noninvasive insulin delivery in rats using the lightweight cymbal array. IEEE Trans Ultrason Ferroelectr Freq Control. 51:176.
40. Lee, S. 2004. Noninvasive ultrasonic transdermal insulin delivery in rabbits using the light-weight cymbal array, Diabetes Technol Ther 6:808.
41. Mitragotri, S., and J. Kost 2000. Low-frequency sonophoresis: A noninvasive method of drug delivery and diagnostics. Biotechnol Prog 16:488.
42. Kost, J., et al. 2000. Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med 6:347.
43. Tezel, A., A. Sens, and S. Mitragotri 2003. A theoretical description of transdermal transport of hydrophilic solutes induced by low-frequency sonophoresis. J Pharm Sci 92:381.
44. Kost, J., and S. Mitragotri. 2000. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm Res 18:1151.
45. Katz, N.P., et al. 2004. Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device. Anesth Analg 98:371.
46. http://www.astrazeneca.com.
47. Becker, B.M., et al. 2005. Ultrasound with topical anesthetic rapidly decreases pain of intravenous cannulation. Acad Emerg Med 12:289.
48. Glenn, G.M., et al. 1998. Skin immunization made possible by cholera toxin. Nature 391:851.
49. Babiuk, S., et al. 2000. Cutaneous vaccination: The skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release 66:199.
50. Roitt, I.M., J. Brostoff, and D. Male. 1998. Immunology, 5th ed. London: Mosby.
51. Stoitzner, P., et al. 2003. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 120:266.
52. Gockel, C.M., S. Bao, and K.W. Beagley. 2000. Transcutaneous immunization induces mucosal and systemic immunity: A potent method for targeting immunity to the female reproductive tract. Mol Immunol 37:537.
53. Glenn, G.M., et al. 1998. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol 161:3211.
54. Tezel, A., et al. 2005. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23:3800.
55. Cao, T., X.J. Wang, and D.R. Roop. 2000. Regulated cutaneous gene delivery: The skin as a bioreactor. Hum Gene Ther 11:2297.
56. Vogel, J.C. 2000. Nonviral skin gene therapy. Hum Gene Ther 11:2253.
57. Uitto, J., and L. Pulkkinen. 2000. The genodermatoses: Candidate diseases for gene therapy. Hum Gene Ther 11:2267.
58. Khavari, P.A., O. Rollman, and A. Vahlquist. 2002. Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252:1.
59. Sieg, A., R.H. Guy, and M.B. Delgado-Charro. 2005. Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technol Ther 7:174.
60. Mitragotri, S., et al. 2000. Transdermal extraction of analytes using low-frequency ultrasound. Pharm Res 17:466.
61. Chuang, H., E. Taylor, and T.W. Davison. 2004. Clinical evaluation of a continuous minimally invasive glucose flux sensor placed over ultrasonically permeated skin. Diabetes Technol Ther 6:21.
62. Lee, S., et al. 2005. Glucose measurements with sensors and ultrasound. Ultrasound Med Biol 31:971.
63. Simonin, J.P. 1995. On the mechanisms of in vitro and in vivo phonophoresis. J Control Release 33:125.
64. Tang, H., et al. 2001. Theoretical description of transdermal transport of hydrophilic permeants:Application to low-frequency sonophoresis. J Pharm Sci 90:545.
65. Tezel, A., A. Sens, and S. Mitragotri. 2003. Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model. J Pharm Sci 92:381.
66. Tezel, A., and S. Mitragotri. 2003. Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys J 85:3502.
67. Kushner, J. IV, D. Blankschtein, and R. Langer. 2004. Experimental demonstration of the existence of highly permeable localized transport regions in low-frequency sonophoresis. J Pharm Sci 93:2733.
68. Tezel, A., et al. 2002. Synergistic effect of low-frequency ultrasound and surfactants on skin permeability. J Pharm Sci 91:91.
69. Mitragotri, S. 2000. Synergistic effect of enhancers for transdermal drug delivery. Pharm Res 17:1354.
70. Meidan, V.M., et al. 1998. Phonophoresis of hydrocortisone with enhancers: An acoustically defined model. Int J Pharm 170:157.
71. Le, L., J. Kost, and S. Mitragotri. 2000. Combined effect of low-frequency ultrasound and iontophoresis:Applications for transdermal heparin delivery. Pharm Res 17:1151.
72. Kost, J., et al. 1996. Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res 13:633.
73. Mitragotri, S., et al. 2000. Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J Pharm Sci 89:892.
74. Lavon, I., N. Grossman, and J. Kost. 2005. The nature of ultrasound-SLS synergism during enhanced transdermal transport. J Control Release 107:484.
75. http://www.wfumb.org.
76. Anonymous. 1998. Update on thermal bioeffects issues. Ultrasound Med Biol 24:S1.
77. Anonymous. 2000. Constructing e-business. Proceedings of the Institution of Civil Engineers, Civil Engineering 138:149.